Pharming Group N.V. (PHAR)

Pharming Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	14.71	-8.51	-12.01	14.99	23.08	44.09
Depreciation & Amortization	15.71	16.07	15.93	13.19	19.61	8.31
Stock-Based Compensation	11.9	11.25	9.25	6.39	9.06	6.54
Other Adjustments	14.88	-2.35	-13.61	-17.95	-10.82	32.67
Change in Receivables	6.71	-6.78	-18.54	2.36	5.92	-7.04
Changes in Inventories	1.24	-0.5	-14.43	-15.02	-6.15	-4.93
Changes in Accounts Payable	-2.94	-2.77	16.23	11.99	-5.19	7.02
Changes in Other Operating Activities	-5.45	-10.4	2.01	-0.88	0.52	-0.9
Operating Cash Flow	53.33	-1.79	-17.3	22.46	37.84	83.63
Operating Cash Flow Growth	11725.72%	-	-	-40.65%	-54.75%	12.07%
Capital Expenditures	-0.61	-0.79	-1.44	-1.38	-10.74	-4.66
Purchases of Intangible Assets	-	-0.01	-0.03	-0.6	-5.98	-10.64
Purchases of Investments	-	-284.31	-382.01	-	-4.59	-
Proceeds from Sale of Investments	137.28	316.73	232.81	7.3	-	-0.33
Other Investing Activities	-	-	21.28	-	-	-
Investing Cash Flow	16.51	31.62	-129.39	5.32	-21.31	-15.63
Long-Term Debt Issued	-	104.54	-	-	-	142.83
Long-Term Debt Repaid	-	-134.92	-	-	-	-57.23
Net Long-Term Debt Issued (Repaid)	-	-30.39	-	-	-	85.59
Issuance of Common Stock	16.66	5.58	8.13	2.28	4.72	2.79
Net Common Stock Issued (Repurchased)	16.66	5.58	8.13	2.28	4.72	2.79
Other Financing Activities	-10.54	-9.61	-9.17	-7.26	-32.67	-27.7
Financing Cash Flow	-1.75	-34.41	-1.04	-4.98	-27.95	60.69
Net Cash Flow	68.09	-4.59	-147.73	22.8	-11.41	128.68
Beginning Cash & Cash Equivalents	-	61.74	207.34	191.92	205.16	74.35
Ending Cash & Cash Equivalents	68.09	109.89	123.48	414.68	383.85	410.32
Free Cash Flow	52.72	-2.58	-18.74	21.08	27.1	78.97
Free Cash Flow Growth	-	-	-	-22.21%	-65.68%	9.73%
FCF Margin	-	-0.87%	-7.64%	10.25%	13.63%	37.22%
Free Cash Flow Per Share	-	-0.03	-0.26	0.30	0.39	1.16
Levered Free Cash Flow	8.79	-39.8	7.75	21.59	14.04	128.18
Unlevered Free Cash Flow	-8.03	-368.3	-245.95	-170.15	-111.79	-30.78

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q